Executive Summary
HHS awarded $132,873,805 in total obligations across two CMS IT delivery orders to private contractors VENTERA LLC ($83.7M) and FLEXION INC ($49.1M), with zero defense-related activity in this civilian-focused stream. Dominant theme is CMS investment in healthcare IT infrastructure (QualityNet) and Medicare claims adjudication (MCADS), both under small business set-asides with significant outlays already ($58.8M for VENTERA, $31.9M for FLEXION).
Highest-conviction signal is bullish on VENTERA LLC's firm fixed-price award, signaling strong execution on a high-materiality $83.7M obligation through 2027. Key risk is VENTERA's high pricing risk under firm fixed terms amid steady outlays. Watch option exercises toward ceilings ($101.7M for VENTERA, $51.1M for FLEXION) and performance to 2027 end dates.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from May 02, 2026.
Investment Signals (2)
- VENTERA LLC Secures $83.7M CMS QualityNet IT Delivery Order (MEDIUM)▲
VENTERA LLC won a $83,737,440 firm fixed-price small business set-aside delivery order from CMS for IT infrastructure under NAICS 518210, with $58.8M already outlayed since April 2023 on a 4+ year contract ending 2027-04-30 (potential 2028). This substantial revenue (~$21M annualized) underscores execution strength for the Arlington, VA-based small business.
- FLEXION INC Lands $49.1M CMS Claims Adjudication Order (MEDIUM)▲
FLEXION INC received a $49,136,365 time and materials delivery order from CMS under small business set-aside for custom programming (NAICS 541511), with $31.9M outlayed since May 2023 toward a 2027 end date. Steady progress supports ~$12M annualized revenue for the Madison, WI firm despite neutral signal.
Risk Flags (2)
- Execution [HIGH RISK]▼
VENTERA LLC faces high contract pricing risk on $83.7M firm fixed-price delivery order, where cost overruns are borne by the contractor amid $58.8M outlays to CMS.
- Execution [MEDIUM RISK]▼
FLEXION INC has medium pricing risk on $49.1M time and materials order to CMS, with flexibility but dependency on labor rates through 2027.
Opportunities (2)
- ◆
VENTERA LLC option exercise toward $101.7M ceiling on CMS QualityNet IT services, building on $58.8M outlays.
- ◆
FLEXION INC potential extension to July 2027 on $49.1M CMS MCADS order under small business set-aside.
Sector Themes (1)
- ◆
Both contracts to CMS total $132.9M for IT services: VENTERA LLC's $83.7M for QualityNet data management (NAICS 518210) and FLEXION INC's $49.1M for claims adjudication programming (NAICS 541511), with high outlays signaling commitment.
Watch List (3)
- 👁
{"entity"=>"VENTERA LLC", "reason"=>"$83.7M CMS obligation with $58.8M outlayed; high materiality award", "trigger"=>"Option exercise to $101.7M ceiling; outlays progress to 2027-04-30"}
- 👁
{"entity"=>"FLEXION INC", "reason"=>"$49.1M CMS obligation with $31.9M outlayed under set-aside", "trigger"=>"Options to $51M; performance end April 2027 vs. potential July 2027"}
- 👁
{"entity"=>"Healthcare IT sector", "reason"=>"Two CMS IT awards totaling $132.9M with steady outlays", "trigger"=>"CMS budget cycles for similar set-asides"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals